-
Cardio Diagnostics (NASDAQ: CDIO) Expands Partnership With Family Medicine Specialists To Bring Specialty Cardiology Tests To Select Walmart Supercenters
Wednesday, February 14, 2024 - 9:10am | 933Read More...A precision cardiovascular medicine company’s innovative AI-driven epigenetic-genetic blood tests will soon be available in one of the nation’s largest retailers. Beginning Q2 2024, Cardio Diagnostics (NASDAQ: CDIO) will bring its advanced blood-based epigenetic-genetic tests, Epi...
-
BlackRock Acquires Stake In Cardio Diagnostics
Thursday, February 8, 2024 - 9:21am | 462Read More...BlackRock (NYSE: BLK) has acquired a minor stake in Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company. In BlackRock’s 13G filing on Feb. 2, they disclosed ownership representing 5.2% of Cardio Diagnostics. Fintel reports that...
-
American Medical Association Grants Cardio Diagnostics (NASDAQ: CDIO) Reimbursement Codes For AI-Powered Coronary Heart Disease Tests
Monday, January 29, 2024 - 10:58am | 1186Read More...Cardio Diagnostics’ AI-driven coronary heart disease (CHD) tests have taken another promising step in their evolution. Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, has been assigned two dedicated Current Procedural...
-
Beyond Diagnosis: Cardio Diagnostics' Actionable Clinical Intelligence Platform Provides Personalized Insights To Help Prevent Heart Attacks
Monday, January 8, 2024 - 9:03am | 803Read More...An artificial intelligence-powered precision cardiovascular medicine company named Cardio Diagnostics (NASDAQ: CDIO) has launched a first-of-its-kind platform called Actionable Clinical Intelligence or ACI, that offers new epigenetic and genetic insights to clinicians prescribing the company’...
-
Cardio Diagnostics' Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association
Friday, December 15, 2023 - 9:07am | 733Read More...Cardio Diagnostics (NASDAQ: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine, has published a potentially revolutionary study in the Journal of the American Heart Association (JAHA). Conducted in collaboration with Intermountain Healthcare and University of...
-
Cardio Diagnostics Establishes A New Partnership To Facilitate Global Footprint And Expansion Beyond North America With India-Based Aimil Ltd.
Friday, November 17, 2023 - 9:04am | 809Read More...Aimil Ltd., one of the companies at the forefront of India’s instrumentation industry, is a leader in introducing innovative technologies to their extensive healthcare network in India. A new Supply and Distribution Agreement with Cardio Diagnostics (NASDAQ: CDIO) has the potential to...
-
With New Lab/Operations Hub, Cardio Diagnostics Says It's Prepared To Meet Uptake In Demand, Announces New Partner Initiative
Monday, November 13, 2023 - 10:09am | 925Read More...Nearly 50% of Americans live with diabetes, obesity, hypertension or another major cardiovascular risk, according to the Centers for Disease Control and Prevention (CDC). For many Americans, the first sign of coronary heart disease (CHD) is a heart attack. A recent announcement by Cardio...
-
Cardio Diagnostics Leverages AI To Combat Cardiovascular Disease
Monday, October 30, 2023 - 8:24am | 897Read More...Cardiovascular disease is the leading cause of death worldwide, accounting for nearly 18 million deaths annually. That amounts to about one-third of all global deaths. Driven by epigenetics and artificial intelligence, what is being referred to as Precision Cardiovascular Medicine could help...
